Citius Pharmaceuticals Inc (CTXR)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CTXR? Forum Prognose Aktiensplit

Finanzdaten der Citius Pharmaceuticals Inc-Aktie (CTXR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	3.9441	-	-	-	-
Cost Of Revenue	0.7892	-	-	-	-
Gross Profit	3.1549	-	-	-	-
Operating Expenses	44.29% 12.17	8.4373	8.788	11.26	10.04
Benefits Costs and Expenses	13.07	-	-	-	-
Costs And Expenses	13.07	-	-	-	-
Operating Income/Loss	6.90% -9.0192	-8.4373	-8.788	-11.26	-10.04
Nonoperating Income/Loss	162.35% -0.1104	-0.0421	-0.1516	0.0134	0.0226
Income/Loss From Continuing Operations Before Tax	7.67% -9.1296	-8.4794	-8.9396	-11.25	-10.28
Income Tax Expense/Benefit, Deferred	0.00% 0.2642	0.2642	0.2642	-	-
Income Tax Expense/Benefit	0.00% 0.2642	0.2642	0.2642	0.2642	0.2642
Income/Loss From Continuing Operations After Tax	7.44% -9.3939	-8.7436	-9.2039	-11.51	-10.28
Net Income/Loss	7.44% -9.3939	-8.7436	-9.2039	-11.51	-10.28
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	49.56% -1.1731	-0.7844	-0.414	-0.595	-
Basic Average Shares	951.18% 21.50	2.0449	11.01	8.5812	-0.5514
Diluted Average Shares	951.18% 21.50	2.0449	11.01	8.5812	-0.5514
Basic Earnings Per Share	245.45% -0.38	-0.11	-0.80	-1.27	-1.31
Diluted Earnings Per Share	245.45% -0.38	-0.11	-0.80	-1.27	-1.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%